<?xml version="1.0" encoding="UTF-8"?>
<p>We also examined the activity of KPF1-Antx hMAb to protect (prophylactic) and treat (therapeutic) pH1N1-infected guinea pigs, as well as to prevent direct contact transmission (
 <xref ref-type="fig" rid="viruses-12-00167-f004">Figure 4</xref> and 
 <xref ref-type="fig" rid="viruses-12-00167-f005">Figure 5</xref>, respectively). KPF1-Antx hMAb showed potent prophylactic and therapeutic activity against pH1N1 infection in guinea pigs (
 <xref ref-type="fig" rid="viruses-12-00167-f004">Figure 4</xref> and 
 <xref ref-type="fig" rid="viruses-12-00167-f005">Figure 5</xref>, respectively), consistent with its in vitro antiviral and HAI properties. Moreover, administration of KPF1-Antx hMAb blocked transmission of pH1N1 infection to sentinel guinea pigs from direct contact with infected animals (
 <xref ref-type="fig" rid="viruses-12-00167-f004">Figure 4</xref> and 
 <xref ref-type="fig" rid="viruses-12-00167-f005">Figure 5</xref>, respectively).
</p>
